D. Borenshtein et al., Cataract development in diabetic sand rats treated with alpha-lipoic acid and its gamma-linolenic acid conjugate, DIABET M R, 17(1), 2001, pp. 44-50
Background Diabetes commonly leads to long-term complications such as catar
act. This study investigated the effects of alpha -lipoic acid (LPA) and it
s gamma -linolenic acid (GLA) conjugate on cataract development in diabetic
sand rats.
Methods Two separate experiments were conducted. In Experiment 1, sand rats
were fed a 'high-energy' diet (70% starch), an acute model of Type 2 diabe
tes, and injected with LPA. In Experiment 2, the animals received a 'medium
-energy' diet (59% starch), a chronic diabetic model, and were intubated wi
th LPA or its GLA conjugate. Throughout the experiments, blood glucose leve
ls and cataract development were measured. At the termination of the experi
ments, lens aldose reductase (AR) activity and lenticular reduced glutathio
ne (GSH) levels were analyzed.
Results LPA injection significantly inhibited cataract development and redu
ced blood glucose levels in rats fed the 'high-energy' diet. Lens AR activi
ty tended to be lower, while lenticular GSH levels increased. In sand rats
fed a 'medium-energy' diet (59% starch), LPA intubation had no effect on bl
ood glucose levels and cataract development but GSH levels were increased.
In contrast, sand rats intubated with GLA conjugate showed the highest bloo
d glucose levels and accelerated cataract development. The conjugate treatm
ent also decreased lenticular GSH content.
Conclusions The hypoglycemic effects of LPA are beneficial in the preventio
n of acute symptoms of Type 2 diabetes. It remains to be shown that the ant
ioxidant activity of LPA is responsible For prevention or inhibition of cat
aract progression in sand rats. Copyright (C) 2000 John Wiley & Sons, Ltd.